2pm – 3.10pm GMT, 2 December 2025 ‐ 1 hour 10 mins
Podium Lecture
Moderators: Richard Armstrong, Philip Breedon
Head of Registries, NEC
Professor of Orthopaedics, Sheffield Teaching Hospitals, Chair, NJR Research Committee
Consultant Orthopaedic Surgeon and Chair, NJR Surgical Performance Committee, Northumbria Healthcare NHS Foundation Trust,
Consultant Trauma & Orthopaedic Surgeon, King's College Hospital NHS Foundation Trust
Professor of Orthopaedics, Sheffield Teaching Hospitals, Chair, NJR Research Committee
Professor Wilkinson's principal research interests are in the genetic and metabolic aspects of joint replacement, osteoarthritis, and other associated diseases. Professor Wilkinson is a key clinical collaborator in the Genetics of Osteoarthritis initiative. He and his collaborators have been instrumental in determining our current understanding of the genetic architecture of osteoarthritis. He conducted the first genome-wide scan into hip dysplasia, and into osteolysis and heterotopic ossification after hip replacement, He published the first study in humans to show that bisphosphonates may suppress bone loss after hip replacement and the first clinical trial to show that the human monoclonal antibody denosumab can inhibit osteolysis lesion activity. Other areas of research include exploration of the molecular mechanisms that underpin osteoarthritis development and identifying potential novel pharmacological strategies for its treatment. He has worked on the genetics of osteoarthritis has uncovered novel gene associations with severity and pattern of hip and knee OA, bone remodelling responses to disease, and hip shape. He also studied the systemic health effects of metal ion exposure after hip resurfacing has demonstrated effects on bone cells, cardiovascular, and other systems.
Professor Wilkinson’s principal funding sources are Versus Arthritis, NIHR, Wellcome, MRC, Royal College of Surgeons of England, Cavendish Foundation, John Charnley Trust and industry.
Consultant Orthopaedic Surgeon and Chair, NJR Surgical Performance Committee, Northumbria Healthcare NHS Foundation Trust,
Professor Mike Reed is a full-time trauma and hip and knee joint replacement surgeon. He trained in the North of England and did fellowships in New Zealand.
He leads Trauma and Orthopaedics at Northumbria Healthcare, working with a team of 31 talented colleagues.
His research focuses on clinical outcomes particularly around short stay surgery as well as infection prevention, diagnosis and management. He has co-developed and commercialised a validated medical device to predict perioperatice risk. Professor Reed is on the steering committee and executive of the National Joint Registry (NJR) and Chaired the Annual Report from 2019-2024. He now leads on Surgical Performance for the NJR, is a trustee for the Orthopaedic Research UK charity and is on the grant awards committee for the National Institute Health and Care Research (NIHR) (i4i PDA). He has led clinical trials for industry and NIHR, and works academically with the University of York.
Consultant Trauma & Orthopaedic Surgeon, King's College Hospital NHS Foundation Trust
Ines Reichert has completed a PhD at Imperial College London prior to her Orthopaedic Training. She is a Consultant Trauma & Orthopaedic Surgeon at King’s College Hospital London a major trauma centre, with subspecialities Upper Limb Hand & Wrist, as well as Diabetic Foot Reconstruction.
She is the R&I Lead for Clinical Research in Trauma & Orthopaedics and leads Undergraduate Teaching in Trauma at her Trust.
Ines Reichert serves nationally on the BOA Research Committee, internationally on the ORS fracture healing section and is President-Elect for the British Orthopaedic Research Society (BORS).
She is specialising in basic science relevant to clinical problems and brings her experience in the conduct of clinical research as well as basic science projects together for improvement of patient care.